(PX) P10 - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US69376K1060
PX: Private Equity, Venture Capital, Impact Investing, Private Credit
P10, Inc. (NYSE: PX) is a leading provider of multi-asset class private market solutions in the alternative asset management industry, specializing in private equity, venture capital, impact investing, and private credit. The company offers a diverse range of investment strategies, including primary fund of funds, secondary investments, and direct and co-investments. Its private equity solutions are marketed under the RCP Advisors, Bonaccord Capital, and P10 Advisors brands, while its venture capital offerings are managed under the TrueBridge brand. Impact investing solutions are provided under the Enhanced brand, and private credit solutions are offered through the Five Points, Hark Capital, and WTI brands. Headquartered in Dallas, Texas, P10, Inc. was established in 1992 and has grown into a prominent player in the alternative asset management sector.
From a technical perspective, PX has shown stability with a 20-day average volume of 507,850 shares. The stock is currently trading at $11.57, slightly above its 20-day SMA of $10.76 but closely aligned with its 50-day SMA of $11.46 and 200-day SMA of $11.58. The Average True Range (ATR) of 0.52 indicates moderate volatility. On the fundamental side, P10, Inc. has a market capitalization of $1.243 billion, with a trailing P/E of 68.88 and a forward P/E of 11.92, suggesting potential valuation adjustments. The price-to-book ratio stands at 3.58, and the price-to-sales ratio is 4.20, while the return on equity is 5.39%.
3-Month Forecast: - Technical Outlook: PX is expected to trade within a narrow range, with support near $10.76 (20-day SMA) and resistance at $11.58 (200-day SMA). The ATR of 0.52 suggests minimal price fluctuations. - Fundamental Analysis: The forward P/E of 11.92 indicates potential upside as earnings estimates are factored in, though the current P/E of 68.88 may signal short-term pressure. - Overall Forecast: PX is likely to remain range-bound in the near term, with potential for modest upside if fundamental improvements align with technical support levels.Additional Sources for PX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PX Stock Overview
Market Cap in USD | 1,297m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2021-10-21 |
PX Stock Ratings
Growth Rating | 60.5 |
Fundamental | 30.7 |
Dividend Rating | 64.0 |
Rel. Strength | 27.8 |
Analysts | 3.8/5 |
Fair Price Momentum | 11.36 USD |
Fair Price DCF | 17.38 USD |
PX Dividends
Dividend Yield 12m | 1.23% |
Yield on Cost 5y | 4.84% |
Annual Growth 5y | 15.31% |
Payout Consistency | 100.0% |
PX Growth Ratios
Growth Correlation 3m | -74.2% |
Growth Correlation 12m | 73.6% |
Growth Correlation 5y | 30.7% |
CAGR 5y | 32.29% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 2.05 |
Alpha | 42.26 |
Beta | 1.550 |
Volatility | 34.55% |
Current Volume | 614.1k |
Average Volume 20d | 460.7k |
As of May 09, 2025, the stock is trading at USD 11.72 with a total of 614,074 shares traded.
Over the past week, the price has changed by +3.99%, over one month by +21.96%, over three months by -13.65% and over the past year by +56.45%.
Neither. Based on ValueRay Fundamental Analyses, P10 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PX as of May 2025 is 11.36. This means that PX is currently overvalued and has a potential downside of -3.07%.
P10 has received a consensus analysts rating of 3.80. Therefor, it is recommend to hold PX.
- Strong Buy: 1
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PX P10 will be worth about 12.9 in May 2026. The stock is currently trading at 11.72. This means that the stock has a potential upside of +10.07%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14.2 | 21.2% |
Analysts Target Price | 14.3 | 22% |
ValueRay Target Price | 12.9 | 10.1% |